SPDR S&P Biotech ETF (XBI) options active amid FDA leadership headlines
Tweet
Share
E-mailSPDR S&P Biotech ETF (NYSE: XBI) 30-day option implied volatility is at 40; compared to its 52-week range of 24 to 62 amid FDA leadership headlines.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James on Monolithic Power Systems (MPWR): 'Full Steam Ahead'
- Nexxen (NEXN) PT Raised to $13 at Needham
- Kenon Holdings (KEN) halted, news pending
Create E-mail Alert Related Categories
OptionsRelated Entities
Standard & Poor's, Options, Maynard Um, Mark Zuckerberg, FDA, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
